221 related articles for article (PubMed ID: 29545472)
1. The dawn of novel STI prevention methods: modelling potential unintended effects of changes in cervical cancer screening guidelines on trichomoniasis.
Rönn MM; Turner KM
Sex Transm Infect; 2018 May; 94(3):161-162. PubMed ID: 29545472
[No Abstract] [Full Text] [Related]
2. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
Lazenby GB; Taylor PT; Badman BS; McHaki E; Korte JE; Soper DE; Young Pierce J
Clin Ther; 2014 Jan; 36(1):38-45. PubMed ID: 24417784
[TBL] [Abstract][Full Text] [Related]
3. Impact of replacing cytology with human papillomavirus testing for cervical cancer screening on the prevalence of
Hui BB; Reulein CP; Guy RJ; Donovan B; Hocking JS; Law MG; Regan DG
Sex Transm Infect; 2018 May; 94(3):216-221. PubMed ID: 29326178
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia.
Garland SM; Tabrizi SN; Chen S; Byambaa C; Davaajav K
Infect Dis Obstet Gynecol; 2001; 9(3):143-6. PubMed ID: 11516062
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer awareness and HPV prevention in Canada.
Kaplan-Myrth N; Dollin J
Can Fam Physician; 2007 Apr; 53(4):693-5, 697. PubMed ID: 17872722
[No Abstract] [Full Text] [Related]
6. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
[TBL] [Abstract][Full Text] [Related]
7. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine.
Cudmore SL; Garber GE
J Infect Public Health; 2010; 3(2):47-53. PubMed ID: 20701891
[TBL] [Abstract][Full Text] [Related]
8. Sexually Transmitted Infections: A Novel Screening Strategy for Improving Women's Health in Vulnerable Populations.
Frati ER; Fasoli E; Martinelli M; Colzani D; Bianchi S; Carnelli L; Amendola A; Olivani P; Tanzi E
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632191
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
Datta SD; Saraiya M
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer: A comprehensive approach towards extermination.
Bava SV; Thulasidasan AK; Sreekanth CN; Anto RJ
Ann Med; 2016; 48(3):149-61. PubMed ID: 26911282
[TBL] [Abstract][Full Text] [Related]
11. Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and HIV in Zambia.
Shanaube K; Ndubani R; Kelly H; Webb E; Mayaud P; Lamberti O; Fitzpatrick J; Kasese N; Sturt A; Van Lieshout L; Van Dam G; Corstjens PLAM; Kosloff B; Bond V; Hayes R; Terris-Prestholt F; Webster B; Vwalika B; Hansingo I; Ayles H; Bustinduy AL
BMJ Open; 2024 Jun; 14(6):e080395. PubMed ID: 38858160
[TBL] [Abstract][Full Text] [Related]
12. Common Sexually Transmitted Infections in Women.
Hodges AL; Holland AC
Nurs Clin North Am; 2018 Jun; 53(2):189-202. PubMed ID: 29779513
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
14. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
Van der Pol B
Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
[No Abstract] [Full Text] [Related]
15. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
16. Role of human papilloma virus testing in cervical cancer prevention.
Fey MC; Beal MW
J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
[TBL] [Abstract][Full Text] [Related]
17. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
[TBL] [Abstract][Full Text] [Related]
18. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
19. Reproductive health care after transplantation.
Krajewski C; Sucato G
Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1222-34. PubMed ID: 25450188
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer prevention: immunization and screening 2015.
Thaxton L; Waxman AG
Med Clin North Am; 2015 May; 99(3):469-77. PubMed ID: 25841595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
